AbbVie (NYSE: ABBV) today announced that new and updated data from its broad solid tumor portfolio will be presented at the 2026 European Society for Medical Oncology (ESMO) Congress, taking place ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results